TGFB1 and neoplasm: Moreover, elraglusib treatment resulted in the decreased gene expression of proapoptotic molecules and regulators of TGFβ signaling which may also contribute to the tumor-suppressive and anti-angiogenic effects of elraglusib that have been previously described [38].